Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded a new Resources entry: Cutaneous neuroendocrine carcinoma with Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange Detected- Revision labels updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows a minor update: Revision v3.4.2 was added and Revision v3.4.1 was removed. This update affects only metadata and does not alter study content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedPlatform revision from v3.4.0 to v3.4.1 with no visible changes to study content, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedUI and labeling updates include adding a glossary toggle, and capitalization/wording changes such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the version tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.